REGN5381
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for REGN5381, covering 2025-06-11 to 2026-01-14. Get the full timeline:
Most recent: Clinical Trial Update: REGN5381 in Adult Participants With Heart Failure With Reduced Ejection Fraction [Phase 2]